You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
For Research Use Only. Not for use in diagnostic procedures. Others Myeloid-NDC RUO Myeloid-NDC PID00001287 10 804 505 001 10804505001 Myeloid-NDC, 48rxn Myeloid-NDC, 48rxn 07613336245675 Reagents, kits 48 reactions Not Available 10 804 483 001 10804483001 Myeloid-NDC, 24rxn Myeloid-NDC, 24rxn 07613336245668 Reagents, kits 24 reactions Not Available 10 804 475 001 10804475001 Myeloid-NDC, 12rxn Myeloid-NDC, 12rxn 07613336245651 Reagents, kits 12 reactions Not Available 10 804 521 001 10804521001 Myeloid-NDC, 96rxn Myeloid-NDC, 96rxn 07613336245682 Reagents, kits 96 reactions Not Available Allows the use of KAPA Target Enrichment probes against targeted human genomic regions. Uncoverdifficult regions with Roche’s renowned probe design expertise● Enrich with higher fidelity probes manufactured with KAPA HiFi DNA polymerase● Experience consistent quality with NGS probe pool QC● Capture more by targeting both strands with biotinylated probes● Achieve superior capture uniformity and reduce PCR duplicates● Increase your sequencing efficiency en The Myeloid-NDC assay has been designed as an integrated tool covering the key genomic alterations recommended for the analysis of acute myeloid leukaemias (AML), myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN).The Myeloid-NDC assay provides a simple solution to allow laboratories to obtain a molecular classification according to the accepted international recommendations, using just a single DNA sample (with no need for an RNA sample).● Myeloid-NDC product targets myeloid malignancies● Integrates:○ Fragmented testing (from multiple sources)○ Mutation profile en